Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Genetic Diversity and Evolution

Evolution of the Hemagglutinin Protein of the New Pandemic H1N1 Influenza Virus: Maintaining Optimal Receptor Binding by Compensatory Substitutions

Robert P. de Vries, Erik de Vries, Carles Martínez-Romero, Ryan McBride, Frank J. van Kuppeveld, Peter J. M. Rottier, Adolfo García-Sastre, James C. Paulson, Cornelis A. M. de Haan
Robert P. de Vries
aVirology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
bDepartments of Cell and Molecular Biology and Chemical Physiology, The Scripps Research Institute, San Diego, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik de Vries
aVirology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carles Martínez-Romero
cDepartment of Microbiology, Icahn School of Medicine Mount Sinai, New York, New York, USA
dGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine Mount Sinai, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan McBride
bDepartments of Cell and Molecular Biology and Chemical Physiology, The Scripps Research Institute, San Diego, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank J. van Kuppeveld
aVirology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter J. M. Rottier
aVirology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adolfo García-Sastre
cDepartment of Microbiology, Icahn School of Medicine Mount Sinai, New York, New York, USA
dGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine Mount Sinai, New York, New York, USA
eDepartment of Medicine, Division of Infectious Diseases, Icahn School of Medicine Mount Sinai, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James C. Paulson
bDepartments of Cell and Molecular Biology and Chemical Physiology, The Scripps Research Institute, San Diego, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelis A. M. de Haan
aVirology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.01955-13
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Fig 1
    • Open in new tab
    • Download powerpoint
    Fig 1

    Sequence variation in the HA protein of pH1N1. Amino acid substitutions at every position of HA of pH1N1 (using all 7,132 HA sequences) were counted per half-year flu season (season I, 1 April 2009 to 30 September 2009, etc.). The most frequent substitutions were plotted (y axis, percent occurrence) for each season. The data for seasons IV to VI were grouped together because of the low number of sequences available for seasons V and VI. The locations of the signal peptide (SP), HA stem, and HA head domains are indicated at the bottom (the drawing is not to scale). The most frequent mutations in the head domain of HA in season III that still prevailed in seasons IV to VI are shaded in black.

  • Fig 2
    • Open in new tab
    • Download powerpoint
    Fig 2

    Receptor-binding avidity of HA proteins with single amino acid substitutions. The effect of the most frequently occurring amino acid substitutions on the binding avidity of soluble HA trimers of pH1N1 was determined by solid-phase binding assay (40 μg/ml HA on fetuin) (OD450, optical density at 450 nm) (A) and hemagglutination (human erythrocytes) (B). HA from strain A/California/07/2009 (Cal07) was used as the template for the introduction of the substitutions indicated on the x axis. (C) The effect of a single amino acid substitution (T200A) on the binding avidity of virus particles was determined by hemagglutination using strain A/California/04/2009 (Cal04) and a recombinant virus of this strain carrying substitution T200A in HA. Equal numbers of viral particles were used on the basis of quantification by quantitative PCR. The average result of four experiments (each performed in triplicate) with independently grown viral stocks is shown. The hemagglutination of the two viruses was significantly different (P < 0.05) (B). Error bars show standard deviations.

  • Fig 3
    • Open in new tab
    • Download powerpoint
    Fig 3

    Phylogenetic tree based on HA of pH1N1. A phylogenetic tree (obtained by neighbor joining) was constructed using full-length viral HA sequences (GenBank accession numbers are listed in Table S2 in the supplemental material) identical to the signature sequence of the cluster (see Materials and Methods) to which it belongs. Cluster numbers describe three properties. The first number (1 to 4) indicates the flu season (seasons I, II, III, and IV to VI, respectively) in which the cluster was the most prominent (as a percentage of the total number of sequences in a season). The decimal number ranks the clusters in order of size. The clusters dominant in season III (given a prefix of 3) and seasons IV to VI (given a prefix of 4) are colored red and blue, respectively. The number after the underscore indicates the number of sequences present in a cluster (all 7,132 sequences were assigned to a cluster). Substitutions defining the branches are indicated. The substitutions for the Cal04 and Cal07 reference strains are indicated in red and were analyzed for their effect on receptor binding.

  • Fig 4
    • Open in new tab
    • Download powerpoint
    Fig 4

    Distribution of HA pH1N1 clusters per flu season. Results for clusters that contained more than 5% of the total number of sequences in any of the seasons are plotted (the y axis indicates the percentage of sequences in a cluster relative to the total number of sequences in a season; e.g., cluster 1.1 harbors 47% of the total number of sequences in season I [green bar], 31% of the sequences in season II [red bar], but only 2% of the sequences in season III [yellow bar]). Clusters are sorted by cluster number on the x axis (numbering is according to that used for the phylogenetic tree and is explained in the legend to Fig. 3). Clusters belonging to clade A or B (Fig. 3) are indicated.

  • Fig 5
    • Open in new tab
    • Download powerpoint
    Fig 5

    Receptor-binding avidity of HA proteins of clades A and B with multiple amino acid substitutions. The effect of amino acid substitutions consecutively occurring during the evolution of clades A (A, C) and B (B, D) on the binding avidity of soluble HA trimers of pH1N1 was determined by a solid-phase binding assay (40 μg/ml HA on fetuin) (A, B) and hemagglutination (human erythrocytes) (C, D). HA from strain A/California/07/2009 (Cal07) was used as the template for the introduction of the substitutions indicated on the x axis.

  • Fig 6
    • Open in new tab
    • Download powerpoint
    Fig 6

    Receptor-binding specificity of HA proteins of clades A and B with multiple amino acid substitutions. Precomplexed HA trimers were applied to a custom-made glycan array. The effect of amino acid substitutions that were introduced into wild-type (Cal07) HA in a stepwise reconstruction of clades A and B was examined. The structures of glycans (arranged in separate panels for N-linked glycans, O-linked glycans, and single-chain glycans attached by an ethyl linker to the array) that were bound (relative fluorescence units are indicated on the y axes) are shown below the panels. Binding was strictly specific for glycans carrying α2-6-linked sialic acids (indicated by purple diamonds in the glycan structure) attached to a β1-4-linked galactose (yellow circles). Blue squares, N-acetylglucosamine; yellow squares, N-acetylgalactosamine; green circles, mannose.

  • Fig 7
    • Open in new tab
    • Download powerpoint
    Fig 7

    Structural model of the amino acid substitutions in clade A and B HA proteins. The two pairs of amino acid substitutions that were shown to compensate for the effects on HA binding of each other are circled in red (panels A and B show clade B mutations S188T/A200T; panels C and D show clade A mutations) in the wild type (A, C) and double-substitution mutants (B, D). The receptor trisaccharide NeuAca(2-6)-Galβ(1-4)-GlcNAc is colored in purple (SIA), yellow (Gal), and blue (GlcNAc). The three structural elements that interact with the receptor are indicated in ribbon presentation (white, 130 and 220 loops; purple, 190 helix). Important backbone and side chain structures are also displayed. Two water molecules involved in a hydrogen bond network (green dotted lines) between residue S186, the 220 loop, and the sialic acid are indicated in red. Substitution S186P disrupts this network by clashes (red dotted lines in panel D) between the hydrophobic proline backbone and both water molecules. Substitution A137T leads to the formation of a new hydrogen bond between the threonine side chain hydroxyl group and the sialic acid. Remarkably, formation of this new bond decreases binding avidity, whereas the disruption of the water-supported network by S186P increases binding.

Tables

  • Figures
  • Additional Files
  • Table 1

    Coevolution of substitution patterns in HA and NA

    ClusteraSubstitution(s) in HANo. of sequences in each clusterNo. (%) of sequences with the indicated mutation in NA
    N44SV241IN396K
    3.8S454N141 (7)4 (29)3 (21)
    4.15S454N, E377K70 (0)1 (14)2 (29)
    4.7S454N, E377K, S188T392 (5)36 (92)37 (95)
    4.2S454N, E377K, S188T, D100N770 (0)74 (96)75 (97)
    3.2S454N, E377K, S188T, A200T5549 (92)50 (94)51 (96)
    4.9S454N, E377K, S188T, A200T, I463T1919 (100)19 (100)19 (100)
    4.1S454N, E377K, S188T, A200T, S146G8682 (95)84 (98)84 (98)
    4.5S454N, E377K, S188T, A200T, S146G, L-7M3333 (100)32 (97)33
    4.1S454N, E377K, S188T, A200T, S146G, N263D1212 (100)12 (100)12 (100)
    • ↵a The cluster number corresponds to the clusters shown in Fig. 3 and 4.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 -

      Table S1 (Accession numbers of all HA protein sequences included in each cluster.)

      XLS, 630K

    • Supplemental file 2 -

      Table S2 (Accession number of the HA protein sequence from each cluster that was used for construction of the phylogenetic tree shown in Fig. 3.)

      XLS, 20K

PreviousNext
Back to top
Download PDF
Citation Tools
Evolution of the Hemagglutinin Protein of the New Pandemic H1N1 Influenza Virus: Maintaining Optimal Receptor Binding by Compensatory Substitutions
Robert P. de Vries, Erik de Vries, Carles Martínez-Romero, Ryan McBride, Frank J. van Kuppeveld, Peter J. M. Rottier, Adolfo García-Sastre, James C. Paulson, Cornelis A. M. de Haan
Journal of Virology Nov 2013, 87 (24) 13868-13877; DOI: 10.1128/JVI.01955-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evolution of the Hemagglutinin Protein of the New Pandemic H1N1 Influenza Virus: Maintaining Optimal Receptor Binding by Compensatory Substitutions
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evolution of the Hemagglutinin Protein of the New Pandemic H1N1 Influenza Virus: Maintaining Optimal Receptor Binding by Compensatory Substitutions
Robert P. de Vries, Erik de Vries, Carles Martínez-Romero, Ryan McBride, Frank J. van Kuppeveld, Peter J. M. Rottier, Adolfo García-Sastre, James C. Paulson, Cornelis A. M. de Haan
Journal of Virology Nov 2013, 87 (24) 13868-13877; DOI: 10.1128/JVI.01955-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514